Literature DB >> 24801463

Ocular and nasal allergy symptom burden in America: the Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) surveys.

Leonard Bielory1, David P Skoner, Michael S Blaiss, Bryan Leatherman, Mark S Dykewicz, Nancy Smith, Gabriel Ortiz, James A Hadley, Nicole Walstein, Timothy J Craig, Felicia Allen-Ramey.   

Abstract

Previous nationwide surveys of allergies in the United States have focused on nasal symptoms, but ocular symptoms are also relevant. This study determines the effects of ocular and nasal allergies on patients' lives. Telephone surveys of randomly selected U.S. households (the patient survey) and health care providers (provider survey) were conducted in the United States in 2012. Study participants were 2765 people ≥5 years of age who had ever been diagnosed with nasal or ocular allergies and 500 health care providers in seven specialties. Respondents to the patient survey reported a bimodal seasonal distribution of allergy symptoms, with peaks in March to May and September. Nasal congestion was the most common of the symptoms rated as "extremely bothersome" (39% of respondents), followed by red, itchy eyes (34%; p = 0.84 for difference in extreme bothersomeness of nasal and ocular symptoms). Twenty-nine percent of respondents reported that their or their child's daily life was impacted "a lot" when allergy symptoms were at their worst. Workers rated their mean productivity at 29% lower when allergy symptoms were at their worst (p < 0.001 compared with no symptoms). Providers reported that itchy eyes was the symptom causing most patients to seek medical treatment by pediatricians (73%), ophthalmologist/optometrists (72%), and nurse practitioners or physician assistants (62%), whereas nasal congestion was the symptom causing most patients to seek treatment from otolaryngologists (85%), allergist/immunologists (79%), and family medicine practitioners (64%). Ocular and nasal allergy symptoms substantially affected patients' lives and were comparable in their impact.

Entities:  

Mesh:

Year:  2014        PMID: 24801463     DOI: 10.2500/aap.2014.35.3750

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  12 in total

1.  Effects of local nasal immunotherapy in allergic airway inflammation: Using urea denatured Dermatophagoides pteronyssinus.

Authors:  Sheng-Jie Yu; En-Chih Liao; Jaw-Ji Tsai
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

3.  Triamcinolone Acetonide versus Fluticasone Propionate in the Treatment of Perennial Allergic Rhinitis: A Randomized, Parallel-Group Trial.

Authors:  Alexander V Karaulov; Tamara Vylegzhanina; Andrey Ovchinnikov; Mariia Chernikova; Nataiya Nenasheva
Journal:  Int Arch Allergy Immunol       Date:  2019-03-15       Impact factor: 2.749

4.  Quality of life issues ranging from the burden of ocular and nasal allergies to the anxiety associated with having to carry self-injectable epinephrine for insect sting allergy.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2014 May-Jun       Impact factor: 2.587

Review 5.  Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis.

Authors:  Mary Barna Bridgeman
Journal:  Integr Pharm Res Pract       Date:  2017-05-04

Review 6.  Recent advances in allergic rhinitis.

Authors:  Flavia C L Hoyte; Harold S Nelson
Journal:  F1000Res       Date:  2018-08-23

7.  Attitudes, practices on allergic rhinitis of three socioeconomic classes of Filipinos in the National Capital Region.

Authors:  Cecilia Gretchen Navarro-Locsin; Joel A Romualdez
Journal:  Asia Pac Allergy       Date:  2016-04-28

8.  Role of antioxidants on the clinical outcome of patients with perennial allergic rhinitis.

Authors:  Bhushan Chauhan; Manish Gupta; Komal Chauhan
Journal:  Allergy Rhinol (Providence)       Date:  2016-01

9.  Treating allergic conjunctivitis: A once-daily medication that provides 24-hour symptom relief.

Authors:  Warner Carr; Jack Schaeffer; Eric Donnenfeld
Journal:  Allergy Rhinol (Providence)       Date:  2016-07-26

10.  The Prevalence of Ocular Allergy and Comorbidities in Chinese School Children in Shanghai.

Authors:  Yanqing Feng; Xiangning Wang; Fang Wang; Rongming Liu; Lu Chen; Shuqin Wu; Xia Yang; Miaoying Chen; Yu-Qing Rao; Jing Li
Journal:  Biomed Res Int       Date:  2017-08-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.